My name is Carla Pereira, and I hold a Nursing degree from the Escola Superior de Enfermagem do Porto (ESEP), which I completed in 2007. Since then, I have worked as a nurse in both Portugal and Switzerland. In 2019, I collaborated in a clinical research study focused on a new immunotherapy treatment for bladder cancer. Currently, I am a MSc student in Health Sciences at the Life and Health Sciences Research Institute (ICVS)/School of Medicine, at the University of Minho. My master’s thesis, titled “Optimizing the Cryopreservation of the Secretome from Induced Mesenchymal Stem Cell-Like Cells: Exploring the Efficacy of Lyophilization,” is being conducted under the supervision of Belém Sampaio-Marques and António J. Salgado.
My name is Carla Pereira, and I hold a Nursing degree from the Escola Superior de Enfermagem do Porto (ESEP), which I completed in 2007. Since then, I have worked as a nurse in both Portugal and Switzerland. In 2019, I collaborated in a clinical research study focused on a new immunotherapy treatment for bladder cancer. Currently, I am a MSc student in Health Sciences at the Life and Health Sciences Research Institute (ICVS)/School of Medicine, at the University of Minho. My master’s thesis, titled “Optimizing the Cryopreservation of the Secretome from Induced Mesenchymal Stem Cell-Like Cells: Exploring the Efficacy of Lyophilization,” is being conducted under the supervision of Belém Sampaio-Marques and António J. Salgado.
Derré. L, et al. (2023) “Intravesical Ty21a treatment of non-muscle invasive bladder cancer induces immune responses that correlate with safety and may be associated to therapy potential” Journal for ImmunoTherapy of Cancer; 11:e008020. DOI: 10.1136/jitc-2023-008020
Lucca, I. et al. (2022) ”Intravesical Ty21a Treatment of Non–muscle-invasive Bladder Cancer Shows a Good Safety Profile” European Urology Open Science, Volume 45, 55 – 58. DOI: 10.1016/j.euros.2022.09.004
We have previously validated the use of the secretome of Mesenchymal Stem Cells (MSCs) from different sources, including those derived from pluripotent stem cells (iMSCs), as a possible therapeutic tool in animal…
Phone: +351 253 604 967
Fax: +351 253 604 809
Email: icvs.sec@med.uminho.pt
Life and Health Sciences
Research Institute (ICVS)
School of Medicine,
University of Minho,
Campus de Gualtar
4710-057 Braga
Portugal
Copyright ©2022 ICVS. All Rights Reserved
Copyright ©2022 ICVS. All Rights Reserved
Life and Health Sciences
Research Institute (ICVS)
School of Medicine,
University of Minho,
Campus de Gualtar
4710-057 Braga
Portugal
Copyright ©2022 ICVS. All Rights Reserved
Life and Health Sciences
Research Institute (ICVS)
School of Medicine,
University of Minho,
Campus de Gualtar
4710-057 Braga
Portugal
